Episode 5 - Stroke Prevention in AFib
Details
In part V of the course in pharmacotherapy in atrial fibrillation (AF) we will discuss stroke prevention in AF, the well-known algorithm that physicians utilize to predict the risk of embolic stroke, using the CHADS-VASc score, and the risk of bleeding complications, using the HASBLED score. However, one must realize that the predictive value of both scores is hampered by the fact that three of the most contributing risk factors are listed in both, a fact that waters out their usefulness. There are surprisingly more well-known risk factors for, e.g., embolic stroke, and we will discuss in depth where the future most likely will take us, integrating biomarkers for risk assessment, and thus steering towards precision medicine.
Sponsors
Dan Atar
Dan Atar is professor of Cardiology at Oslo University Hospital in Oslo, Norway. Features in 8...
Read MoreDan Atar is professor of Cardiology at Oslo University Hospital in Oslo, Norway. Features in 8 videos on Wondr Medical. Dan speaks about clinical cardiology topics, covering areas such as acute coronary syndromes, heart failure, atrial fibrillation, antithrombotic therapies and secondary CV prevention. He has a particular interest in pharmacotherapy within these fields.
Show Less
Marita Knudsen Pope
Marita Knudsen Pope is a MD at University Of Oslo, Institute of Clinical Medicine, Dept. of...
Read MoreMarita Knudsen Pope is a MD at University Of Oslo, Institute of Clinical Medicine, Dept. of Cardiology, Oslo, Norway.
Show Less
